AUSTIN, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced management’s participation in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8 – 10, 2025 in New York City. Rick Barry, President and Chief Executive Officer, will ...

Core Viewpoint - GCL Global Holdings Ltd has successfully completed the compulsory acquisition of Ban Leong Technologies Limited, which will be delisted from the Singapore Stock Exchange, marking a significant milestone for both companies in enhancing their market presence and operational capabilities [1][3]. Company Overview - GCL Global Holdings Ltd is a leading provider of games and entertainment, with a focus on bridging Asian-developed intellectual property to a global audience [5]. - Ban Leong Technologies Limited has been a prominent distributor of technology products in Asia for over three decades, offering a wide range of products including IT accessories, gaming components, and smart devices [2][9]. Acquisition Details - The acquisition of Ban Leong is expected to unlock new opportunities, fuel innovation, and enhance GCL's ability to deliver technology solutions across Asia [3]. - Ban Leong will leverage GCL's global ecosystem and distribution network to accelerate growth and create value for customers and partners [3][4]. Strategic Synergies - The combination of GCL and Ban Leong is anticipated to result in significant synergies, including operational efficiencies, economies of scale, and new revenue streams [4]. - Initiatives such as introducing branded gaming devices pre-installed with GCL game titles and expanding B2C offerings for gaming peripherals are planned to enhance market positioning [4].

Core Insights - DMG Blockchain Solutions Inc. reported its fiscal third quarter 2025 financial results, highlighting advancements in bitcoin mining and AI infrastructure, alongside a focus on digital asset custody for long-term growth [1][3]. Financial Performance - Revenue for Q3 2025 was $11.6 million, a decrease of 8% from $12.6 million in Q2 2025, but an increase of 40% from $8.3 million in Q3 2024 [4][9]. - Bitcoin mined in Q3 2025 totaled 84 bitcoin, down from 91 bitcoin in Q2 2025 and 87 bitcoin in Q3 2024 [9]. - The net loss for Q3 2025 was $0.4 million, an improvement from a net loss of $3.3 million in Q2 2025 [9]. Cost Structure - Operating and maintenance expenses increased to $6.5 million in Q3 2025 from $4.7 million in the same period last year, primarily due to higher utility costs and hosting fees [5][6]. - General and administrative costs rose to $1.9 million in Q3 2025, up from $1.5 million in the prior year, driven by increased professional fees and wages [6]. Asset and Investment Overview - Total assets as of June 30, 2025, were $133.6 million, reflecting a 20% increase from $111.5 million a year earlier, largely due to short-term investments and digital currency revaluation [7][9]. - Cash, short-term investments, and digital assets amounted to $61.8 million at the end of Q3 2025, remaining stable compared to Q2 2025 [9]. Strategic Initiatives - The company has fully operationalized 6 megawatts of hydro-enabled bitcoin mining and is advancing its AI infrastructure strategy with a new 2-megawatt data center [3]. - DMG is positioning its Systemic Trust digital asset custody business to leverage the growth of digital asset funds and treasuries [3].

Core Points - Airgain, Inc. will participate in the 2025 Gateway Conference on September 3-4 in San Francisco, CA [1] - The presentation will be led by President and CEO Jacob Suen and CFO Michael Elbaz on September 4 at 10:30 a.m. PT, with a live webcast available [2] - Management will discuss the execution of its growth strategy, including key milestones such as FirstNet Trusted certification for AC-Fleet and the launch of the Go-Kit Pro mobile connectivity solution [3] Company Overview - Airgain, Inc. is headquartered in San Diego, California, and is a leading provider of advanced wireless connectivity solutions [5] - The company focuses on delivering high-performance, cost-effective, and energy-efficient wireless solutions across three primary markets: enterprise, automotive, and consumer [5]

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders, today announced that the Company will present at the following upcoming conferences: EVENT: 36th International Epilepsy Congress, Lisboa Congress Centre, Lisbon, PortugalDATE: August 30 – September ...

Company Overview - Bionano Genomics, Inc. is a provider of genome analysis solutions aimed at addressing complex questions in biology and medicine [3] - The company's mission is to transform genome visualization through optical genome mapping (OGM) solutions, diagnostic services, and software [3] - Bionano offers OGM solutions applicable in basic, translational, and clinical research, along with a platform-agnostic genome analysis software and nucleic acid extraction solutions using proprietary isotachophoresis (ITP) technology [3] Upcoming Conference - Erik Holmlin, PhD, the CEO of Bionano, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025 [1] - The presentation is scheduled from 3:00 p.m. to 3:30 p.m. ET [2] - A recording of the session will be available on the Bionano website for at least 30 days following the conference [2]

Core Viewpoint - Playboy, Inc. has successfully converted all remaining Series B Convertible Preferred Stock into common stock, reflecting its ongoing efforts to improve its balance sheet and reduce debt [1][2][3] Group 1: Conversion Details - The conversion resulted in 12,439,730 shares of common stock being issued at a conversion price of $1.74448 per share, which is over 6% higher than the common stock's closing price on August 21, 2025 [2] - The conversion price also represents a more than 16% premium compared to the price during the company's private placement of common stock in Q4 2024 [2] - Following the conversion, Playboy has no preferred stock outstanding and a total of 107,548,055 shares of common stock [2] Group 2: Financial Impact - As of the conversion date, the company reported approximately $128 million in net debt, which is a reduction of about $70 million over the past year [2] - The Board of Directors believes the company's share price is undervalued and anticipates undiscounted interest savings of $6.992 million through the remaining term of the Series B Stock, which was set to mature at the end of 2027 [3] Group 3: Company Overview - Playboy, Inc. is a global pleasure and leisure company with a mission to create a culture where all people can pursue pleasure, operating in approximately 180 countries [4] - The company has a history of over 70 years in creating media and hospitality experiences while advocating for cultural progress based on equality and freedom of expression [4]

Core Insights - Locafy Limited is participating in the 2025 Gateway Conference on September 3-4, 2025, in San Francisco, CA [1] - CEO Gavin Burnett will present on September 3 at 9:00 am PT and will also hold one-on-one meetings with investors and analysts [2] - The presentation will highlight Locafy's recent momentum, including AI-powered product launches and strategic partnerships, aimed at creating a scalable growth model [3] Company Overview - Founded in 2009, Locafy aims to revolutionize the US$700 billion SEO sector by helping businesses enhance their search engine relevance through an automated approach [4]

Core Insights - Amarin Corporation will present new data on icosapent ethyl (IPE) at the European Society of Cardiology (ESC) Congress 2025, highlighting its cardioprotective effects [1][2] - The data will focus on IPE's role in reducing cardiovascular risk through various mechanisms, including inflammation and lipoprotein oxidation [2][3] Presentation Highlights - New analyses from the REDUCE-IT trial will evaluate the clinical benefits of IPE, including its impact on hospitalization risk and duration [2][3] - Mechanistic studies will explore the effects of eicosapentaenoic acid (EPA) on inflammasome activation and pro-inflammatory protein expression in endothelial cells [2][3] Educational Initiatives - Amarin will support educational programming addressing residual cardiovascular risk, featuring presentations by medical and scientific leaders in Europe [3][5] Symposium and Abstracts - Moderated poster presentations will include topics such as the reduction of cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome and the impact of IPE across different apolipoprotein B and triglyceride levels [4][7] - Oral presentations will cover the effects of IPE on hospitalization risks and the modulation of inflammasome activation in macrophages [7] Company Overview - Amarin is focused on advancing cardiovascular disease management and understanding residual cardiovascular risk beyond traditional therapies [8] - The company has a global presence with offices in the United States, Ireland, Switzerland, and partnerships worldwide [8] Product Information - VASCEPA (icosapent ethyl) is the first FDA-approved treatment solely comprising IPE, aimed at high-risk patients with persistent cardiovascular risk despite statin therapy [9] - Since its launch, VASCEPA has been prescribed over 25 million times and is covered by most major medical insurance plans [9]

IRVING, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, is confirmed to present at the 2025 Annual Gateway Conference, which is being held September 3-4 at the Four Seasons Hotel in San Francisco, CA. Sow Good’s management team is scheduled to present on Thursday, September 4th at 9:00 a.m. Pacific Time (PT). The presentation will be webcast live and available for replay here. In addition to the ...